Pharmaceutical

Enveric’s EB-003 selected as lead candidate for mental health disorders

Enveric Biosciences has selected EB-003 as its lead drug candidate from its EVM301 series for difficult-to-treat mental health disorders.

Dec 30, 2023 - 18:00
Enveric’s EB-003 selected as lead candidate for mental health disorders
Enveric Biosciences has selected EB-003 as its lead drug candidate from its EVM301 series for difficult-to-treat mental health disorders.
Read the original article

Tags:

Previous Article

FDA warns of rare hypersensitivity reaction due to antiseizure drugs

Next Article

Greener and feasible production: Enzymatic methods for mono- and diacylglycerol ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

In a first, fetal cell organoids generated from amniotic fluid, new study reports

In a first, fetal cell organoids generated from amnioti...

Mar 4, 2024

What makes a drug a blockbuster — or a cautionary tale?

What makes a drug a blockbuster — or a cautionary tale?

Feb 3, 2024

A 988 operator, faced with a flood of calls, turns to AI to boost counselor skills

A 988 operator, faced with a flood of calls, turns to A...

Jun 22, 2023